Flexion Therapeutics Inc

Flexion Therapeutics — Q4 2019 Earnings Presentation

7 slides from Flexion Therapeutics's earnings presentation, Mar 12, 2020

  1. Slide 1: Commercial Metrics Overview

    Commercial Metrics Overview March 12, 2020 Exhibit 99.2

  2. Slide 2: Commercial Metrics Overview

    Commercial Metrics Overview ZILRETTA® net sales of $23.7 million in the fourth quarter of 2019 We have called on almost all of our 4,972 target accounts 3,488 accounts have purchased ZILRETTA, as of December 31, 2019; up from 3,130, as of September 30, 2019 2,642 accounts have re-ordered ZILRETTA (7

  3. Slide 3: ZILRETTA Net Sales Quarterly

    ZILRETTA Net Sales Quarterly Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy

  4. Slide 4: Distribution of Accounts by ZILRETTA Purchases Cumulative

    Distribution of Accounts by ZILRETTA Purchases Cumulative Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics and certain medical centers or hospitals) then subsequently purchase ZILRETTA directly from these specialty distributors

  5. Slide 5: Distribution of ZILRETTA Purchases by Accounts Cumulative

    Distribution of ZILRETTA Purchases by Accounts Cumulative Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics and certain medical centers or hospitals) then subsequently purchase ZILRETTA directly from these specialty distributors

  6. Slide 6: ZILRETTA Purchases by New and Existing Accounts Cumulative

    ZILRETTA Purchases by New and Existing Accounts Cumulative Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics and certain medical centers or hospitals) then subsequently purchase ZILRETTA directly from these specialty distributors

  7. Slide 7: Flexion: Transformative Medicine... Where It Matters

    clevion Transformative Medicine... Where It Matters

Flexion Therapeutics — Q4 2019 Earnings Presentation on 6ix